Stryker Corp (SYK)
$232.72
1.72 (0.75%)
SYK Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
86.97B
PE Ratio
87.16
EPS
2.67
Volume (Avg. Vol.)
136,657
Day's Range
229.57 - 233.16
52-Week Range
124.54 - 242.51
Dividend & Yield
1.88 (0.81%)
SYK Stock Predictions, Articles, and Stryker Corp News
3 Big Stock Charts for Wednesday: Stryker, Zoetis, and Coty
These health and beauty names are struggling at the moment — and their 3 big stock charts suggest the trend could get worse.
Stryker Earnings: SYK Stock Falls on Q1 EPS Beat, Weak Q2 Guidance
Stryker posted its quarterly earnings results after the bell today, amassing earnings that topped expectations, but SYK stock took a hit.
7 Stocks to Buy to Survive a Bear Market
These seven stocks are resisting widespread market volatility and will help investors with surviving a bear market. Here's what you need to know about each.
Is This the Latest Booster for Medtronic PLC Stock?
The FDA approval of Medtronic's (MDT) ActivaProgramming Application should help give MDT stock a boost in the months ahead.
Boston Scientific Corporation Stock Surges on Potential Stryker Takeover
Boston Scientific (BSX) stock was soaring Monday on talk of a possible takeover by Stryker (SYK), but details are still scarce.
3 Stocks to Watch on Wednesday: Illumina, Inc. (ILMN), Juniper Networks, Inc. (JNPR) and Stryker Corporation (SYK)
Illumina (ILMN) earnings were 22 cents above expectations, Juniper Networks's (JNPR) revenue above $5 billion for 2017 and Stryker's (SYK) income swings to a loss.
Stryker Corporation’s (SYK) Superior Earnings Growth Keep it a Buy
Stryker Corporation (NYSE:SYK) is one of 161 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 782 company GICS Health Care sector. SYK has a market value of $56.8 billion which is in the top 10% of its industry group. Portfolio Grader's current ranking for SYK puts it 28 among the 161 companies in this industry group, putting in the top quartile; in the top quartile of the sector with a ranking of 92 among the 782 companies in the sector, and number 578 in the nearly 5,000 company Portfolio Grader universe.
Quant Score Keeps Stryker Corporation (SYK) Shares a Buy
Stryker Corporation (NYSE:SYK) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, with a market value of $58.3 billion. From an investment attractiveness viewpoint, SYK is ranked in the top quartile of the sector with a ranking of 93 among the 782 companies in the sector; the stock's Portfolio Grader ranking places it 27 among the 161 companies in this industry group, giving it a well above-average position and number 565 in the 5000 company Portfolio Grader company universe.
Stryker Corporation’s (SYK) Earnings Growth Makes it Buy
The current recommendation of Buy for Stryker Corporation (NYSE:SYK) is derived using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been downgraded from a Strong Buy to a Buy in the last week.
Exceptional Earnings Growth Keeps Stryker Corporation (SYK) a Strong Buy
Stryker Corporation (NYSE:SYK) is one of 161 companies within the Health Care Equipment & Supplies GICS industry group, which is in turn part of the 781 company GICS Health Care sector. SYK has a market value of $58.1 billion which is in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 161 companies in this industry group, putting it in the top decile; in the top decile of the sector with a ranking of 36 among the 781 companies in the sector, and number 211 in the nearly 5,000 company Portfolio Grader universe.
Outstanding Analytics for Earnings Growth Keep Stryker Corporation (SYK) a Strong Buy
Currently, Stryker Corporation (NYSE:SYK) has a Strong Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SYK has had from Portfolio Grader for 4 months.
High-Level Metrics for Earnings Momentum Keep Stryker Corporation (SYK) a Strong Buy
Stryker Corporation (NYSE:SYK) is ranked as a Strong Buy using Louis Navellier's investing methodology and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SYK has had from Portfolio Grader for 4 months.
Stryker Corporation (SYK) a Strong Buy on Top-End Earnings Momentum
Stryker Corporation (NYSE:SYK) is one of the 783 companies in the GICS Health Care sector, and a component of the 163 company Health Care Equipment & Supplies GICS industry group within this sector. SYK's market value is $59.7 billion which places it in the top decile in its industry group. The stock's current Portfolio Grader score places it 14 among the 163 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 29 among the 783 companies in the sector, and number 180 in the nearly 5,000 company Portfolio Grader universe.
Stryker Corporation (SYK) a Strong Buy on Outstanding Quant Score
Stryker Corporation (NYSE:SYK) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 3 months.
High-Level Quant Score Makes Stryker Corporation (SYK) a Strong Buy
As one of the 783 companies in the GICS Health Care sector Stryker Corporation (NYSE:SYK) is a constituent of the 162 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of SYK is $54.9 billion which places it in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 162 companies in this industry group, positioning it among the leaders; in the top decile of the sector with a ranking of 33 among the 783 companies in the sector, and number 320 in the nearly 5,000 company Portfolio Grader universe.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
